Self-Monitoring of Blood Glucose in Type 2 Diabetes | Zendy

Timothy Davis | Zendy; Wendy A. Davis | Zendy; A J Farmer | Zendy; Juan José Gagliardino | Zendy; Carlo Giorda | Zendy; Philip Home | Zendy; Lig Ji | Zendy; Jennal Johnson | Zendy; A. J. Karter | Zendy; H Kolb | Zendy; Steven Martin | Zendy; V. Mohan | Zendy; Antonio Nicolucci | Zendy; Massimo Porta | Zendy; A. Ramachandran | Zendy; Kaushik Ramaiya | Zendy; Jayendra H. Shah | Zendy; A. Samad Shera | Zendy; S. Skei | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Self-Monitoring of Blood Glucose in Type 2 Diabetes

Author(s) -

Timothy Davis,

Wendy A. Davis,

A J Farmer,

Juan José Gagliardino,

Carlo Giorda,

Philip Home,

Lig Ji,

Jennal Johnson,

A. J. Karter,

H Kolb,

Steven Martin,

V. Mohan,

Antonio Nicolucci,

Massimo Porta,

A. Ramachandran,

Kaushik Ramaiya,

Jayendra H. Shah,

A. Samad Shera,

S. Skei

Publication year - 2007

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc07-0951

Subject(s) - medicine , diabetes mellitus , type 2 diabetes , blood glucose self monitoring , continuous glucose monitoring , type 1 diabetes , intensive care medicine , endocrinology

AUTHORS Elizabeth A.C. Haidar, MSc, BSc, AHEA, RN, is lecturer and advanced nurse practitioner, King’s College London; Andrew C. Burden, FRCP, MD, is community diabetologist, Heart of Birmingham Teaching PCT; John R. Skelton, MRCGP, MA, BA, RSA, is professor of clinical communication, University of Birmingham. ABSTRACT Haidar, E.A.C. et al (2008) Self-monitoring of blood glucose in type 2 diabetes. Nursing Times; 104: 3, 32–33. The aim of this study was to assess the effect of self-monitoring of blood glucose (SMBG) on glycaemic control in type 2 diabetes. An observational prospective study with historical controls was carried out in a socially deprived general practice. HbA1c and fasting blood glucose (FBG) were checked at three, six and nine months and compared with baseline data. There was a significant difference between pre-SMBG HbA1c (mean 9.8%, SD +/-2.4) and post-SMBG (mean 8.5%, SD+/-2.1). SMBG improved glycaemic control in patients with type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research